维普中文期刊产品整合服务
31篇 您的检索式:作者名="Wychowski"
    题名 作者 年代 出处 被引量
1Characterization of truncated forms of hepatitis C virus glycoproteins显示文摘Michalak J P Wychowski C Choukhi A 1997J Gen Virol1997,78,:1
2Charac- terization of the hepatitis C virus-encoded serine proteinase: determination of proteinase-dependent polyprotein cleavage sites 显示文摘GRAKOUI A MCCOURT D WYCHOWSKI C 1993J Virol1993,67,5:1
3Expression and Identification of Hepatitis C Virus Polyprotein Cleavage Products显示文摘Grakoui A Wychowski C Rice C M 0,,03:1
4Additional Glycosylation Within a Specific Hypervariable Region of Subtype 3a of Hepatitis C Virus Protects Against Virus Neutralization显示文摘Sadia Anjum Ahmed Wahid Muhammad Sohail Afzal Anna Albecka Khaled Alsaleh Tahir Ahmad Thomas F. Baumert Czeslaw Wychowski Ishtiaq Qadri Fran?ois Penin Jean Dubuisson 2013Journal of Infectious Diseases2013,,11:1
5Characterization of the hepatitis C virus-encoded serine proteinase: determination of proteinase-dependent polyprotein cleavage sites显示文摘Grakoui A McCourt D W Wychowski C 1993J Virol1993,67,:1
6Induction of hepatitis C virus E1 envelope protein-specific immune response can be enhanced by mutation of N-glycosylation sites 显示文摘Fournillier A Wychowski C Boucreux D 2001J Virol2001,75,12:1
7Highly infectious plasmids carrying poliovirus cDNA are capable of replication in transfected cells显示文摘Katherine M Kean Wychowski C 1986Virology1986,59,2:1
8Charged residus in the transmembrane domains of hepatitis C virus glycoproteins play a key role in the processing, subcellular localization and assembly of these envelope proteins 显示文摘Cocquerel L Wychowski C Minner F 2002J Virol2002,74,8:1
9HCV-specific immune responses induced by CIGB-230 in combination with IFN-α plus ribavirin显示文摘AIM:To analyze hepatitis C virus(HCV)-specific immune responses in chronically infected patients under triple therapy with interferon-α(IFN-α)plus ribavirin and CIGB-230.METHODS:CIGB-230 was administered in different schedules with respect to IFN-αplus ribavirin therapy.Paired serum and peripheral blood mononuclear cells(PBMC)samples from baseline and end of treatment were analyzed.The HCV-specific humoral response was tested by enzyme-linked immunosorbent assay,neutralizing antibodies were evaluated by cell culture HCV neutralization assays,PBMC proliferation was assayed by carboxyfluorescein succinimidyl ester staining and IFN-γsecretion was assessed by enzyme-linked immunospot.Data on virological and histological response and their association with immune variables are also provided.RESULTS:From week 12 to week 48,all groups of patients showed a significant reduction in mean leukocyte counts.Statistically significant reductions in antibody titers were frequent,but only individuals immunized with CIGB-230 as early add-on treatment sustained the core-IgG response,and the neutralizing antibody response was enhanced only in patients receiving CIGB-230.Cell-mediated immune responses also tended to decline,but significant reductions in IFN-γsecretion and total absence of core-specific lymphoproliferation were exclusive of the control group.Only CIGB-230-immunized individuals showed de novo induced lymphoproliferative responses against the structural antigens.Importantly,it was demonstrated that thequality of the CIGB-230-induced immune response depended on the number of doses and timing of administration in relation to the antiviral therapy.Specifically,the administration of 6 doses of CIGB-230 as late addon to therapy increased the neutralizing antibody activity and the de novo core-specific IFN-γsecretion,both of which were associated with the sustained virological response.CONCLUSION:CIGB-230,combined with IFN-α-based therapy,modifies the immune response in chronic patients.The study provides evidence for the design of more effective therapeutic vaccine interventions against HCV.Yalena Amador-Caizares Gillian Martínez-Donato Liz lvarez-Lajonchere Claudia Vasallo Mariacarla Dausá Daylen Aguilar-Noriega Carmen Valenzuela Ivette Raíces Jean Dubuisson Czeslaw Wychowski Zurina Cinza-Estévez Marlén Castellanos Magdalys Núez Anny Armas Yaimé González Ismariley Revé Ivis Guerra ngel Pérez Aguiar Santiago Dueas-Carrera 2014World Journal of Gastroenterology2014,20,1:1
10Induction of hepatitis C virus El envelope protein-specific immune response can be enhanced by mutation of N-glycosylation sites显示文摘Fouruillier A Wychowski C Boucreux D 2001J Virol2001,75,12:1
11Cymlovirin-N inhibits hepatitis C virus entry by binding to envelope protein glycmls显示文摘HELLE F WYCHOWSKI C VU-DACU N 2006Journal of Biological Chemistry2006,281,25:1
12Involvement of endoplasmic reticulum chaperones in the folding of hepatitis C virus glycoproteins显示文摘Choukhi A Ung S Wychowski C 1998J Virol1998,72,:1
13Cyanovirin-N inhibitshepatitis C virus entry by binding to envelope protein glycans 显示文摘Helle F Wychowski C Vu-Dac N 2006J Biol Chem2006,281,25:1
14Cyanovirin-N inhibits hepatitis C vires entry by binding to envelope protein glycans显示文摘Francois H Czeslaw Wychowski Ngoc Vu-Dac 2006The Journal of Biological Chemistry2006,281,25:1
15Dabigatran-induced gastrointestinal bleeding in an elderly patient with moderate renal impairment 显示文摘Wychowski MK Kouides PA 2012Ann Pharmacother2012,46,4:1
16Role of N-linked glycans in the functions of hepatitis C virus envelope proteins incorporated into infectious virions显示文摘Helle F Vieyres G Elkrief L Popescu C I Wychowski C Descamps V Castelain S Roingeard P Duverlie G Dubuisson J 2010J Virol2010,84,11:1
17Characterization of the hepa2titis C virus Encoded serine proteinase:determination of proteinase dependedpolyprotein cleavage sites显示文摘Grakoui A McCourt D W Wychowski C 1993Journal of Virology1993,67,:1
18Cyanovirin-N inhibits hepatitis C virus entry by binding to envelope protein glyeans 显示文摘Helle F Wychowski C Vu-Dac N 2006J Biol Chem2006,281,25:1
19Cyanovirin N inhibits hepatitis C virus entry by binding to envelope pro- tein glycans 显示文摘Helle F Wychowski C Vu-Dac N etal 2006J Biol Chem2006,281,25:1
20Dabigatran-induced gas- trointestinal bleeding in an elderly patient with moderate renal impairment显示文摘WYCHOWSKI M K KOUIDES P A 2012Ann Pharmacother2012,46,4:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费